Standard Biotools Inc (LAB)vsStryker Corporation (SYK)
LAB
Standard Biotools Inc
$0.73
-1.72%
HEALTHCARE · Cap: $324.80M
SYK
Stryker Corporation
$332.71
+5.25%
HEALTHCARE · Cap: $127.55B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 29197% more annual revenue ($25.27B vs $86.25M). LAB leads profitability with a 90.7% profit margin vs 13.2%. SYK earns a higher WallStSmart Score of 55/100 (C-).
LAB
Hold45
out of 100
Grade: D+
SYK
Buy55
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LAB.
Margin of Safety
-49.0%
Fair Value
$223.22
Current Price
$332.71
$109.49 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Keeps 91 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Large-cap with strong market position
Areas to Watch
4.6% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -16.8% — below average capital efficiency
Expensive relative to growth rate
Premium valuation, high expectations priced in
2.6% revenue growth
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LAB
The strongest argument for LAB centers on Price/Book, Profit Margin, Debt/Equity. Profitability is solid with margins at 90.7% and operating margin at -44.5%.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap.
Bear Case : LAB
The primary concerns for LAB are Revenue Growth, EPS Growth, Market Cap.
Bear Case : SYK
The primary concerns for SYK are PEG Ratio, P/E Ratio, Revenue Growth.
Key Dynamics to Monitor
LAB carries more volatility with a beta of 1.38 — expect wider price swings.
LAB is growing revenue faster at 4.6% — sustainability is the question.
SYK generates stronger free cash flow (415M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SYK scores higher overall (55/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Standard Biotools Inc
HEALTHCARE · MEDICAL DEVICES · USA
Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools and technologies. The firm's focus on developing high-performance products for laboratories in genomics and proteomics is aimed at improving research precision and operational efficiency. Utilizing proprietary platforms, Standard Biotools accelerates scientific discoveries, reinforcing its position as a leader in the dynamic biotechnology landscape. With a commitment to meeting the growing demand for innovative analytical solutions, LAB is strategically positioned to facilitate significant advancements within the life sciences sector.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?